ISPIRE TECHNOLOGY INC Stock Price, News & Analysis

Ispire Technology (NASDAQ: ISPR) and IKE Tech responded to the U.S. Food and Drug Administration's new enforcement direction under the Nov. 17, 2025 continuing resolution that requires the FDA to allocate at least $200 million of its $712 million in user fees to ENDS enforcement and to fund a multi-agency task force with $2 million for removing illegal imports.

Both companies promoted their blockchain-enabled, FDA-submitted System-on-a-Chip and age-verification solutions as technology to enable real-time product tracing, device-level identity validation, and interoperability to curb illicit disposable vapes and protect youth in the $30 billion flavored vape market.

Ispire Technology (NASDAQ: ISPR) will host its fiscal first quarter 2026 earnings conference call at 8:00 am ET on Thursday, November 6, 2025 to discuss results for the quarter ended September 30, 2025.

Dial-in numbers: US 844-826-3033 or International +1 412-317-5185; ask for the "Ispire Technology Call." The call will be webcast live at https://viavid.webcasts.com/starthere.jsp?ei=1738889&tp_key=82f919c8ba (register 15 minutes early to install audio software).

A replay will be available through midnight ET on Thursday, November 20, 2025 via dial 844-512-2921 or +1 412-317-6671 using passcode 10203874.

Ispire Technology Inc. (NASDAQ: ISPR) reported challenging financial results for fiscal year 2025, with revenue declining to $127.5 million from $151.9 million in FY2024. The company's strategic shift from cannabis to nicotine sectors led to decreased gross profit of $22.6 million and widened net loss to $39.2 million.

Key developments include progress in PMTA activities through IKE Tech LLC joint venture, featuring blockchain-based age verification technology. The company reported $18M in backlog orders entering Q1 2026 and implemented cost-cutting measures resulting in $10.2 million in annual payroll savings. As of June 30, 2025, Ispire maintained $24.4 million in cash and cash equivalents with working capital of $0.4 million.

Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has scheduled its fiscal fourth quarter and full year 2025 earnings conference call for September 16, 2025, at 8:00 AM ET.

The call will discuss financial results for the period ended June 30, 2025. Investors can access the call through North American toll-free number (877-451-6152) or International number (+1 201-389-0879). A live webcast will be available, and a replay will be accessible until September 30, 2025, using passcode 13755309.

Ispire Technology's joint venture IKE Tech will showcase its innovative vaping safety technologies at the World Vape Show Dubai from June 18-20, 2025. John Patterson, IKE Tech's president and Ispire's SVP of International Nicotine, will participate in a panel on consumer safety and harm reduction alongside industry leaders. The company will highlight its blockchain-based age-gating and Smart-Tag authentication technologies, which achieved 100% effectiveness in preventing underage access during clinical trials. Notably, their age-verification system is under FDA review as the first standalone age-gating system for ENDS (Electronic Nicotine Delivery Systems). The event will feature hands-on demonstrations of their vaping technology, with key executives including Jamie Kennaugh and Alex Yumshtyk in attendance.

Ispire Technology Inc. (NASDAQ: ISPR) has issued a clarification regarding its Malaysian subsidiary's operations, emphasizing full compliance with local regulations. The company confirmed that its Johor facility exclusively manufactures vaporizer hardware for export, with no local distribution or production of nicotine/cannabis-containing products. Key points include: strict export-only manufacturing protocols, production limited to semi-finished vaporizer hardware without liquids or gels, and planned integration of blockchain-based safety features including age-gating and geo-fencing technology. The company has committed over USD 50 million in investment to establish a premier manufacturing hub in Southeast Asia. Ispire also clarified that recent cannabis-related product references pertained only to U.S. operations where such products are legal, not Malaysian activities.

Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, will participate in the Benzinga Cannabis Capital Conference in Chicago on June 10-11, 2025. Dennis Lider, SVP of Cannabis, will join a panel discussion titled 'The Hidden Winners in Cannabis: Profitable Businesses Without the Red Tape' focusing on successful ancillary cannabis companies. The announcement follows a significant milestone where IKE Tech, Ispire's joint venture, received an FDA Acceptance Review letter for its blockchain-enabled age-gating system PMTA, advancing to the filing review phase. The panel, scheduled for June 10 at 11:00 am CDT, will feature executives from Rx Green Technologies, HARA Supply, and Grove Bags, discussing opportunities in the cannabis industry without direct plant-touching operations.

Ispire Technology (NASDAQ: ISPR) announced that IKE Tech, its joint venture, will present at the 7th Annual Next Generation Nicotine Delivery USA Conference in Miami. The presentation follows IKE Tech's groundbreaking PMTA filing with the FDA for a Bluetooth Low Energy System-on-a-Chip featuring blockchain-enabled age verification for ENDS devices. This marks the first complete PMTA submission for a universal, interoperable age-verification component. John Patterson, SVP of International Nicotine at Ispire and IKE Tech president, will discuss youth vaping challenges and their technology solution at a panel on June 4. The system implements continuous, real-time identity verification, going beyond traditional point-of-purchase age checks. IKE Tech has received an Acceptance Review letter from the FDA and requested expedited review citing public health benefits.

Ispire Technology Inc. (NASDAQ: ISPR) has secured a groundbreaking interim license from the Malaysian Government for nicotine product manufacturing. The company becomes the first and only entity in Malaysia with comprehensive authorization for export, import, and production of nicotine products.

The interim license enables immediate commencement of manufacturing operations. Ispire plans to expand its Malaysian facility from the current 6 production lines to 80 lines. The company expects to receive the final license in the coming months, completing its regulatory requirements in Malaysia.

This strategic move aims to diversify Ispire's production base and mitigate geopolitical pricing risks, positioning the company as a leading international vaping hardware provider.